Effects of a Mobile App-Based Mindfulness Intervention in Persons with Spinal Cord Injury and Chronic Pain
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Mar 17, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a mobile app can help people with spinal cord injuries (SCI) who also experience chronic pain. The study will compare two different programs over six weeks: one that focuses on mindfulness (a way to help manage stress and pain) and another that provides general health education. Researchers want to see if using the mindfulness app can reduce pain, help with feelings of depression and anxiety, and improve daily life for participants.
To be eligible for this study, participants should have had a spinal cord injury for at least six months and experience chronic pain that is rated as moderately severe or worse. They must also be comfortable using the internet and able to understand the study's instructions. Participants will need a smartphone or tablet to use the app, and those who have been using meditation regularly or have significant hearing or vision problems won't be able to join. The trial is not yet recruiting participants, but when it starts, those involved can expect to engage with the app for a few weeks and share their experiences through surveys.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Traumatic SCI of at least 6 months duration
- • Chronic pain \[defined as pain lasting at least 3 months with a pain intensity rating of 4 or higher on a 10-point visual analog scale\]
- • Understand spoken and written English sufficiently to provide informed consent, participate in the intervention and complete study surveys
- Exclusion Criteria:
- • Lack of daily internet access
- • inability to demonstrate comprehension of informed consent by correctly answering 4 out of 5 questions about the study
- • Significant visual/hearing impairment that does not allow use of the MM app's audiovisual presentations
- • Use of any meditation more than once a week in the last 3 months
- • Inability to provide or obtain an email address for registration to the AC intervention and/or communication with study staff
- • inability to provide a phone number for communication with study staff
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Radha Korupolu, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported